Matches in Wikidata for { <http://www.wikidata.org/entity/Q91623925> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q91623925 description "article scientifique publié en 2019" @default.
- Q91623925 description "artículu científicu espublizáu en xunetu de 2019" @default.
- Q91623925 description "im Juli 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91623925 description "scientific article published on 04 July 2019" @default.
- Q91623925 description "wetenschappelijk artikel" @default.
- Q91623925 description "наукова стаття, опублікована 4 липня 2019" @default.
- Q91623925 name "Exceptional 4-year response to 177Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer" @default.
- Q91623925 name "Exceptional 4-year response to 177Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer" @default.
- Q91623925 type Item @default.
- Q91623925 label "Exceptional 4-year response to 177Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer" @default.
- Q91623925 label "Exceptional 4-year response to 177Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer" @default.
- Q91623925 prefLabel "Exceptional 4-year response to 177Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer" @default.
- Q91623925 prefLabel "Exceptional 4-year response to 177Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer" @default.
- Q91623925 P1433 Q91623925-1E867261-34BF-4D64-BE79-5D01152CC975 @default.
- Q91623925 P1476 Q91623925-A1417EC8-14FF-4196-A374-DFC8A88E1BA7 @default.
- Q91623925 P2093 Q91623925-1D85F9AE-CE4F-4884-8D9C-59CF874939AD @default.
- Q91623925 P2093 Q91623925-684E6FF8-24F8-46FE-92DD-4DC08451E533 @default.
- Q91623925 P2093 Q91623925-713291BB-A602-41CF-8FFF-B0A0CCCDFA77 @default.
- Q91623925 P2093 Q91623925-73607D50-45ED-409A-A5EB-1CE2E1D51EE4 @default.
- Q91623925 P2093 Q91623925-A39A989D-7858-4C85-A2A7-4E0795D1C459 @default.
- Q91623925 P304 Q91623925-5B586E2C-0EDA-449A-9FD0-1B75B15E93B4 @default.
- Q91623925 P31 Q91623925-B5E2BFD0-CF6D-4DF3-B1EB-105A8187383E @default.
- Q91623925 P356 Q91623925-E3230464-9888-45FA-8FCE-6EF56577D045 @default.
- Q91623925 P433 Q91623925-3116F429-2606-4B44-B7A4-85103A1AC97C @default.
- Q91623925 P478 Q91623925-2A70109D-4A51-46F8-AB79-D357ABD94D7D @default.
- Q91623925 P50 Q91623925-A1AF4A44-A9BA-4BF5-93B3-C79A16CF6B9C @default.
- Q91623925 P577 Q91623925-A5E65835-7E56-485B-98A6-326C3A05B859 @default.
- Q91623925 P698 Q91623925-B5DF694F-2B6F-4168-98DC-8A8F193DB584 @default.
- Q91623925 P356 S00259-019-04410-8 @default.
- Q91623925 P698 31273434 @default.
- Q91623925 P1433 Q15708890 @default.
- Q91623925 P1476 "Exceptional 4-year response to 177Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer" @default.
- Q91623925 P2093 "Calogero D'Alessandria" @default.
- Q91623925 P2093 "Hui Wang" @default.
- Q91623925 P2093 "Matthias Eiber" @default.
- Q91623925 P2093 "Robert Tauber" @default.
- Q91623925 P2093 "Wolfgang A Weber" @default.
- Q91623925 P304 "2212-2213" @default.
- Q91623925 P31 Q13442814 @default.
- Q91623925 P356 "10.1007/S00259-019-04410-8" @default.
- Q91623925 P433 "10" @default.
- Q91623925 P478 "46" @default.
- Q91623925 P50 Q91623921 @default.
- Q91623925 P577 "2019-07-04T00:00:00Z" @default.
- Q91623925 P698 "31273434" @default.